The South African National Aids Council is meant to play a co-ordinating role in the country’s response to HIV, bringing ...

As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...

The national HIV prevalence was 16.3% among adults aged 15 years and older, translating to an estimated 7.4 million adults ...

Sweden has surpassed the UNAIDS 95-95-95 targets, with reduced HIV incidence and a steady increase in diagnosed and treated ...

Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without ...

Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without ...

Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for ...

Mpox’s present echoes HIV’s past—it’s a disease that has the potential to affect everyone and is more dangerous within a ...

As the nation's AIDS walk marks its 40th year in Los Angeles, organizers say medical advances have taken lowered visibility ...

EDP-323 is an investigational inhibitor of Respiratory Syncytial Virus (RSV), currently showing promising results in Phase 2a ...

A man who identified himself as an HIV/AIDS advocate complained about the bad treatment they received from healthcare workers. “When we get there late, we are shouted at and they told that we ...

The HIV treatment market is projected to be worth $5-7 billion, more than double the current level, with potential for further expansion. Gilead and GSK, which together account for 90% of the ...